LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced today the addition of David D. O’Toole as the Company’s vice president and chief financial officer. In his role as CFO, Mr. O’Toole will be responsible for all aspects of financial management for Response Genetics.
